These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8602388)

  • 1. Assessment of the time course of drugs with inhibitory effects on hepatic metabolic activity using successive salivary caffeine tests.
    Soto J; Alsar MJ; Sacristan JA
    Pharmacotherapy; 1995; 15(6):781-4. PubMed ID: 8602388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of salivary caffeine tests to assess the inducer effect of a drug on hepatic metabolism.
    Soto J; Sacristan JA; Alsar MJ
    Ann Pharmacother; 1996; 30(7-8):736-9. PubMed ID: 8826551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in vitro and in vivo inhibition of cytochrome P450 CYP1A2, CYP2D6, and CYP3A by H2-receptor antagonists.
    Martínez C; Albet C; Agúndez JA; Herrero E; Carrillo JA; Márquez M; Benítez J; Ortiz JA
    Clin Pharmacol Ther; 1999 Apr; 65(4):369-76. PubMed ID: 10223772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of the paraxanthine/caffeine ratio in the saliva of patients with liver cirrhosis].
    Perlík F; Pucelíková T; Slanar O
    Cas Lek Cesk; 2001 Feb; 140(2):51-3. PubMed ID: 11262908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time response of cytochrome P450 1A2 activity on cessation of heavy smoking.
    Faber MS; Fuhr U
    Clin Pharmacol Ther; 2004 Aug; 76(2):178-84. PubMed ID: 15289794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of inhibitory effect of cimetidine on caffeine metabolism in children using the caffeine breath test.
    Parker AC; Pritchard P; Preston T; Dalzell AM; Choonara I
    Br J Clin Pharmacol; 1997 May; 43(5):467-70. PubMed ID: 9159560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of pefloxacin and enoxacin with the human cytochrome P450 enzyme CYP1A2.
    Kinzig-Schippers M; Fuhr U; Zaigler M; Dammeyer J; Rüsing G; Labedzki A; Bulitta J; Sörgel F
    Clin Pharmacol Ther; 1999 Mar; 65(3):262-74. PubMed ID: 10096258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of concomitant administration of cimetidine and phenobarbital on antipyrine elimination and metabolite formation.
    Sonne J; Døssing M; Poulsen HE; Pilsgaard H; Rasmussen B; Loft S
    Int J Clin Pharmacol Ther Toxicol; 1987 Apr; 25(4):194-6. PubMed ID: 3583468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of venlafaxine on CYP1A2-dependent pharmacokinetics and metabolism of caffeine.
    Amchin J; Zarycranski W; Taylor KP; Albano D; Klockowski PM
    J Clin Pharmacol; 1999 Mar; 39(3):252-9. PubMed ID: 10073324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum metabolite/caffeine ratios as a test for liver function.
    Jodynis-Liebert J; Flieger J; Matuszewska A; Juszczyk J
    J Clin Pharmacol; 2004 Apr; 44(4):338-47. PubMed ID: 15051740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot study of the effect of antipyrine on caffeine kinetics in six healthy volunteer subjects.
    Soto J; Alsar MJ
    J Clin Pharm Ther; 1997 Jun; 22(3):191-5. PubMed ID: 9447474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic and hormonal effects of caffeine: randomized, double-blind, placebo-controlled crossover trial.
    MacKenzie T; Comi R; Sluss P; Keisari R; Manwar S; Kim J; Larson R; Baron JA
    Metabolism; 2007 Dec; 56(12):1694-8. PubMed ID: 17998023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of major tanshinones isolated from Danshen (Salvia miltiorrhiza) on rat CYP1A2 expression and metabolism of model CYP1A2 probe substrates.
    Wang X; Lee WY; Or PM; Yeung JH
    Phytomedicine; 2009 Aug; 16(8):712-25. PubMed ID: 19403289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cigarette smoking and carbon monoxide on chlorzoxazone and caffeine metabolism.
    Benowitz NL; Peng M; Jacob P
    Clin Pharmacol Ther; 2003 Nov; 74(5):468-74. PubMed ID: 14586387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased systemic clearance of caffeine due to cimetidine.
    Broughton LJ; Rogers HJ
    Br J Clin Pharmacol; 1981 Aug; 12(2):155-9. PubMed ID: 7306430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of repeat dosing with cimetidine on the pharmacokinetics of intravenous granisetron in healthy volunteers.
    Youlten L
    J Pharm Pharmacol; 2004 Feb; 56(2):169-75. PubMed ID: 15005875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orally given melatonin may serve as a probe drug for cytochrome P450 1A2 activity in vivo: a pilot study.
    Härtter S; Ursing C; Morita S; Tybring G; von Bahr C; Christensen M; Röjdmark S; Bertilsson L
    Clin Pharmacol Ther; 2001 Jul; 70(1):10-6. PubMed ID: 11452239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lansoprazole and ethanol metabolism: comparison with omeprazole and cimetidine.
    Battiston L; Tulissi P; Moretti M; Pozzato G
    Pharmacol Toxicol; 1997 Dec; 81(6):247-52. PubMed ID: 9444664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intra-individual comparison of the long term effect of Non-Ovlon on caffeine pharmacokinetics].
    Meyer FP; Canzler E; Giers H; Walther H
    Zentralbl Gynakol; 1988; 110(22):1449-54. PubMed ID: 2464882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.